Anti-IL21R Neutralizing Antibody (V3S-0622-YC4667) (CAT#: V3S-0622-YC4667)

Send Inquiry
  • fig1
    Figure 1 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in WB
  • fig1
    Figure 2 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in DB
  • fig1
    Figure 3 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with IL21R. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; WB; DB; FuncS
Application Notes The antibody is recommended for detection of IL21R by FuncS assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IL21R
Alternative Name IL21R; interleukin 21 receptor; NILR; CD360; interleukin-21 receptor; IL-21 receptor; novel interleukin receptor
Gene ID 50615
UniProt Q9HBE5
Research Area Signal Pathway

Tested Data

WB

Figure 1 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in WB

Western blot analysis of V3S-0622-YC4667 was performed by loading human IL21R protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0622-YC4667 and HRP goat anti-IgG (H+L) as a secondary antibody (1: 3000). Chemiluminescent detection was performed.

Figure 1 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in WB

DB

Figure 2 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in DB

Dot Blot analysis of V3S-0622-YC4667 was performed by coating with human IL21R protein (His tag).

V3S-0622-YC4667 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-IgG (H+L) as a secondary antibody (1: 3000)
NC: Negative control, PC: Positive control

Figure 2 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in DB

ELISA

Figure 3 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in ELISA

ELISA analysis of V3S-0622-YC4667 was performed by coating with human IL21R protein (His tag). Then blocked with BSA and incubated with V3S-0622-YC4667. The HRP-conjugated goat anti-IgG as a secondary antibody (1: 2000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-Human IL21R Monoclonal Antibody (V3S-0622-YC4667) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry